Medical Supplies for Pandemics Act of 2021
- Last Action
- 5/24/2021
Actions
- 2021-05-24Referred to the Subcommittee on Health.
- 2021-05-21Referred to the House Committee on Energy and Commerce.
- 2021-05-21Introduced in House
- 2021-05-21Introduced in House
CRS Summary
As of 2021-05-21 (00)
Medical Supplies for Pandemics Act of 2021
This bill requires the Department of Health and Human Services (HHS) to undertake various actions to enhance supply chain elasticity for and maintain domestic reserves of critical medical supplies for the Strategic National Stockpile.
Specifically, HHS must increase emergency stocks of supplies, geographically diversify production of supplies, and enter cooperative agreements or partnerships for purposes of supporting domestic production of supplies and replenishing supplies in the stockpile. The department's authority to enter such agreements and partnerships terminates on September 30, 2024.
Cosponsors (6)
- Jackie Walorski (R-IN)
- Thomas Suozzi (D-NY)
- Mike Levin (D-CA)
- William Timmons (R-SC)
- David Cicilline (D-RI)
- Carolyn Bourdeaux (D-GA)
Subjects
- Congressional oversight
- Emergency medical services and trauma care
- Health programs administration and funding
- Health technology, devices, supplies
- Immunology and vaccination
- Manufacturing
- Medical tests and diagnostic methods
- Prescription drugs
- Public contracts and procurement
- Strategic materials and reserves
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.